Mark R. Sullivan
Overview
Mark R. Sullivan received $938K in total compensation, including $457K in salary, at Eleven Biotherapeutics in 2019.
Source: SEC filing on March 30, 2020.
Related executives
We found 16 more executives who work or worked at Eleven Biotherapeutics.
Steven Kelly
Eleven Biotherapeutics
Chief Executive Officer
Thomas Cannell
Eleven Biotherapeutics
Chief Executive Officer
Richard Morris
Eleven Biotherapeutics
Chief Financial Officer
Michael Klichinsky
Eleven Biotherapeutics
Chief Scientific Officer
Monica Forbes
Eleven Biotherapeutics
Chief Financial Officer
Mark Sullivan
Eleven Biotherapeutics
General Counsel
Glen MacDonald
Eleven Biotherapeutics
Chief Technology Officer
Stephen Hurly
Eleven Biotherapeutics